secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2023-12-14T23:59:59+00:00
Accession:  0001493152-23-044891
Event type: other_material
Sentiment:  negative
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaCell's BriaPro subsidiary posts Q1 loss of $128K; holds $211K in intangible assets
--------------------------------------------------------------------------------

- BriaPro completed spin-out from BriaCell on Aug 31, 2023, receiving Bria-TILsRx and PKCδ inhibitor assets.
- Net loss of $128K for three months ended Oct 31, 2023; no revenue; operating loss $132K.
- Intangible assets (patents) of $211K net; cash and equivalents of $1; accumulated deficit $148K.
- Going concern uncertainty noted; BriaPro needs additional financing to continue operations.
- BriaCell owns 2/3 of BriaPro; provides transition services for $20K/month.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315223044891/0001493152-23-044891-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315223044891/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-044891

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer